A regional HIV grant with a checkered history and serial problems in its aim to respond to stigma and human rights challenges across Latin America and the Caribbean has been discontinued for its failure “to deliver on the original goal of reducing stigma and discrimination and promoting understanding of human rights and gender equity among military and the police,” according to a recommendation by
You are here
Technical Review Panel (TRP)
When the Global Fund Board approved early applicant funding for Myanmar for all three diseases (see first article in this newsletter), it also approved funding for the renewal of existing grants for these diseases. The total funding approved for Myanmar is shown in the following table:
When the Global Fund Board approved early applicant funding for El Salvador for HIV under the new funding model (NFM), it also approved funding for the renewal of two existing HIV grants. The amount of renewal funding approved was $3.9 million. When combined with the $20.2 million in NFM indicative funding and the $2.9 million in NFM incentive funding, total funding awarded to El Salvador was $27.0 million.
The Technical Review Panel (TRP) has provided feedback on its review of the first wave of concept notes. This article provides a summary of what the TRP said.
Five Concept Notes from Early Applicants Have Been Endorsed, and Have Moved to the Grant-Making Stage
Five concept notes submitted by early applicants have been endorsed by the Grant Approvals Committee (GAC). Three of the concept notes are from the country coordinating mechanism (CCM) in Myanmar (one for each disease). The others are from CCMs in El Salvador (HIV) and Zimbabwe (HIV). This information was contained in the 15 May issue of the Global Fund’s News Flash.
In the report to the Board on TFM proposals, the Technical Review Panel (TRP) devoted a large section to lessons learned from its review of the proposals. This article provides a summary of the lessons learned that apply to all proposals. (In a separate article, we describe the observations of the TRP that relate to the proposals for each of the three diseases.)
In the report to the Board on Transitional Funding Mechanism (TFM) proposals, the Technical Review Panel (TRP) made observations specific to each of the disease components. This article provides a summary of these observations. (In a separate article, we describe the lessons learned identified by the TRP with respect to all proposals.)
TRP's Report on Round 10 Provides Clues to What Applicants Should Include in Their Round 11 Proposals
Here is a question for consultants and committees writing proposals for Round 11: Would you like to know now what the Technical Review Panel (TRP) wants to see in the proposals when it reviews them early in 2012?
It appears likely that the demand for funding in Round 10 will be about the same as it was in Round 9. The Global Fund has released preliminary figures indicating that the total two-year cost for all Round 10 applications amounts to $4.36 billion.
According to the Global Fund'sOffice of the Inspector General (OIG):